Form 4 Filing: Stock Option Grant to Jean Pierre Garnier

Jean Pierre Garnier, a director at BioAge Labs, Inc., was granted 22,000 stock options on June 10, 2026. The options have an exercise price of $15.48 and will vest on the earlier of the next annual meeting or the one-year anniversary of the grant date, provided continued service. These options are for BioAge Labs, Inc. Common Stock. The transaction was reported on Form 4, filed on June 12, 2026.